// App-Quantinova.ai

1098 : MiR-203 suppresses cutaneous squamous cell carcinoma growth and targets the myc oncogene

Researchers

Presenter

  • Warangkana Lohcharoenkal

Principal Investigators

  • Masako Harada

  • Jakob Loven

  • Florian Meisgen

  • Ning Xu Landen

  • Lingyun Zhang

  • Liisa Nissinen

  • Veli-Matti Kahari

  • Mona Stahle

  • Eniko Sonkoly

  • Dan Grander

  • Marie Arsenian-Henriksson

  • Andor Pivarcsi

Medical Centers

  • Karolinska Institutet, Stockholm, Sweden

  • Whitehead Institute for Biomedical Research and MIT, Cambridge, MA

  • MediCity Research Laboratory, Turku, Finland

  • University of Turku and Turku University Hospital, Turku, Finland.

Locations

  • United States

  • Sweden

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Cutaneous squamous cell carcinoma

  • Melanoma

  • Solid malignancies

Biomarkers

  • Proliferating cell nuclear antigen

  • Epidermal growth factor receptor

  • Hepatocyte growth factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved